Studies blood-thinning drugs in stroke patients with small brain bleeds
Observes blood-thinning drugs in adults with ischemic stroke and brain microbleeds.
Plain-language title generated from the registry record
Registry title: Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
Key facts
- Where
- Ankang, Hanzhong, Xi'an, Xi’an, Xianyang, Ya'an, Yan’an, and Yunlin, ChinaSee the 16 sites
Where in China
- Ankang Central HospitalAnkang, ChinaTaking people
- 3201 HospitalHanzhong, ChinaTaking people
- Hanzhong People's HospitalHanzhong, ChinaTaking people
- 986 HospitalXi'an, ChinaTaking people
- Department of Neurology, Xijing Hospital, Fourth Military Medical UniversityXi'an, ChinaTaking people
- Gaoling District HospitalXi'an, ChinaTaking people
- Gem Flower Xi'an Changqing Staff HospitalXi'an, ChinaTaking people
- Tangdu HospitalXi'an, ChinaTaking people
- The First Affiliated Hospital of Xi'an Medical UniversityXi'an, ChinaTaking people
- Xi'an Gaoxin HospitalXi’an, ChinaTaking people
- No.215 Hospital of Shaanxi nuclear industryXianyang, ChinaTaking people
- The First People's Hospital of XianyangXianyang, ChinaTaking people
- Xian Yang Central HospitalXianyang, ChinaTaking people
- Yan'an University Affiliated HospitalYa'an, ChinaTaking people
- Yan'an People's HospitalYan’an, ChinaTaking people
- Yulin No.2 HospitalYunlin, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Xijing Hospital
- Trial code
- NCT05032053
- Record updated
- 30 July 2026
- Original description
To observe the effect of different antithrombotic drugs on the prognosis of ischemic stroke patients with cerebral microbleeds. And further combined with proteomic methods to explore serological markers that can be used to accurately predict the prognosis of such patients.Read full original descriptionShow less
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
To observe the effect of different antithrombotic drugs on the prognosis of ischemic stroke patients with cerebral microbleeds. And further combined with proteomic methods to explore serological markers that can be used to accurately predict the prognosis of such patients.
Inclusion: Patients diagnosed clinically as ischemic stroke; Age ≥ 40 years; Onset time ≤ 3 months; Informed consent was signed.
Exclusion: There are contraindications for antithrombotic drugs use; Patients with symptomatic intracranial hemorrhage; bleeding lesion > 10 mm was found on SWI; Vascular malformations, tumors, abscesses or other major non ischemic brain diseases were present; Serious systemic diseases; Refusal to sign informed consent or poor compliance.